Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment

Pediatric Infectious Disease Journal

Volumn 19, Issue 9, 2000, Pages 862-871

  Smith, Renee ^a   Malee, Kathleen ^b   Charurat, Manhattan ^c   Magder, Larry ^c   Mellins, Claude ^a   MacMillan, Carol ^d   Hittleman, Joan ^e   Lasky, Tamar ^c   Llorente, Antolin ^f   Moye, Jack ^g  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c INSTITUTE OF HUMAN VIROLOGY   (United States)

^d Columbia College of Physicians and Surgeons ^*  (United States)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Developmental outcome; Early vs. late infant infection; Pediatric human immunodeficiency virus type 1 infection

Indexed keywords

ARTICLE; DISEASE PREDISPOSITION; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM FUNCTION; PERINATAL INFECTION; PHENOTYPE; PRIORITY JOURNAL; VERTICAL TRANSMISSION;

CHILD DEVELOPMENT; CHILD, PRESCHOOL; COGNITION DISORDERS; DISEASE TRANSMISSION, VERTICAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOTOR SKILLS DISORDERS; NERVOUS SYSTEM; TIME FACTORS;

EID: 0033829825     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200009000-00010     Document Type: Article

References (45)

1. Early cognitive and motor development among infants born to women infected by human immunodeficiency virus
2. Effects of pediatric HIV infection and prenatal drug exposure on mental and psychomotor development
3. Effect of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life
4. Receptive and expressive language function of children with symptomatic HIV infection and relationship with disease parameters: A longitudinal 24 month follow-up study
5. Impairment of expressive behavior in pediatric HIV infected patients with evidence of CNS disease
6. A descriptive survey of pediatric human immunodeficiency virus-infected long term survivors
7. Morbidity and mortality in European children vertically infected by HIV
8. Older children and adolescents living with perinatally acquired human immunodeficiency virus
9. AIDS appearance in children is associated with the velocity of disease progression in their mothers
10. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery
11. Maternal predictors of perinatal human immunodeficiency virus transmission
12. Report of a consensus workshop, Maternal factors involved in mother-to-child transmission of HIV-1, Siena, Italy, January 17 to 18, 1992
13. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease
14. Perinatal infection by human immunodeficiency virus type 1 (HIV-1): Relationship between proviral copy number in vivo, viral properties in vitro, and clinical outcome
15. Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection
16. Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth: The Women and Infants Transmission Study (WITS)
17. Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: Importance of viral RNA and the timing of transmission on long-term outcome
18. Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children
19. Proposed definitions for in utero versus intrapartum transmission of HIV-1
20. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model
21. + lymphocytes in HIV-1 exposed infants with early positive HIV cultures: A possible early marker of intrauterine transmission. Women and Infants Transmission Study Group
22. Thymic dysfunction and time of infection predict mortality in human immunodeficiency virus-infected infants. CDC Perinatal AIDS Collaborative Transmission Study Group
23. Viral load and disease progression in infants with human immunodeficiency virus type-1
24. Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type I infection
25. Issues relevant to the transmission of HIV: Current clinical insights regarding transmission
26. Relationship between cognitive and immune functioning in children born to HIV-1 seropositive women
27. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection
28. Guidelines for flow cytometric immunophenotyping: A report from the National Institute of Allergy and Infectious Diseases, Division of AIDS
29. Interlaboratory variability of CD subset measurements by flow cytometry and its application to multi-center clinical trials
30. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group
31. Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection
32. Use and interpretation of anthropometric indicators of nutritional status
33. Lymphocyte phenotyping in infants: Maturation of lymphocyte subpopulations and the effects of HIV infection
34. Maternal drug use in perinatal HIV studies: The Women and Infants Transmission Study
35. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age
36. An approach to the analysis of repeated measures
37. Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy
38. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
39. Adaptive behavior of children with symptomatic HIV infection before and after zidovudine therapy
40. Effect of continuous infusion zidovudine on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection
41. Brain growth and cognitive improvement in children with human immune deficiency virus-induced encephalopathy after six months of continuous infusion zidovudine therapy